Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

1 day ago 6

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease vaccine after a late-stage trial.

Read Entire Article

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Related

Dogecoin Eyes 300% Upside As Analyst Flags Major Reversal Zo...

Ethereum Rebounds 6%, But Coinbase Demand Remains Weak

Expert Says Ripple’s XRP Is Designed For More, Here’s What H...

Trending

Popular

Singapore man gets 2-year sentence for involvement in $6.9M ...

XRP jumps 3% as breakout above $1.39 ends early-2026 downtre...

Trader swaps $50M on Aave but receives just 324 AAVE — here’...

Bitcoin Returns Mirror Late-2022 Levels Seen Before 67% Rall...

The S&P 500 just broke a major support. Another 10% decline ...

Will Markets React to $1.9B Bitcoin Options Expiring Today?

A key inflation gauge just logged its highest reading in alm...

Bitcoin 'passing geopolitical stress test' as BTC price spik...

BlackRock’s staked ether ETF draws $15 million in first-day ...

Bitcoin's building steam and a $3 billion trigger could make...